• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床肺移植后原发性移植物功能障碍的重点综述:一种多水平综合征

A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome.

机构信息

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Lung Transplant Unit, Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.

Department of Thoracic Surgery, University Hospitals Leuven, 3000 Leuven, Belgium.

出版信息

Cells. 2022 Feb 21;11(4):745. doi: 10.3390/cells11040745.

DOI:10.3390/cells11040745
PMID:35203392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8870290/
Abstract

Primary graft dysfunction (PGD) is the clinical syndrome of acute lung injury after lung transplantation (LTx). However, PGD is an umbrella term that encompasses the ongoing pathophysiological and -biological mechanisms occurring in the lung grafts. Therefore, we aim to provide a focused review on the clinical, physiological, radiological, histological and cellular level of PGD. PGD is graded based on hypoxemia and chest X-ray (CXR) infiltrates. High-grade PGD is associated with inferior outcome after LTx. Lung edema is the main characteristic of PGD and alters pulmonary compliance, gas exchange and circulation. A conventional CXR provides a rough estimate of lung edema, while a chest computed tomography (CT) results in a more in-depth analysis. Macroscopically, interstitial and alveolar edema can be distinguished below the visceral lung surface. On the histological level, PGD correlates to a pattern of diffuse alveolar damage (DAD). At the cellular level, ischemia-reperfusion injury (IRI) is the main trigger for the disruption of the endothelial-epithelial alveolar barrier and inflammatory cascade. The multilevel approach integrating all PGD-related aspects results in a better understanding of acute lung failure after LTx, providing novel insights for future therapies.

摘要

原发性移植物功能障碍(PGD)是肺移植(LTx)后急性肺损伤的临床综合征。然而,PGD 是一个涵盖肺移植物中持续发生的病理生理和生物学机制的总称。因此,我们旨在对 PGD 在临床、生理、放射、组织学和细胞水平上的相关内容进行重点综述。PGD 根据低氧血症和胸部 X 射线(CXR)浸润情况进行分级。高等级 PGD 与 LTx 后的不良预后相关。肺水肿是 PGD 的主要特征,它会改变肺顺应性、气体交换和循环。传统的 CXR 可以粗略估计肺水肿,而胸部 CT 则可以进行更深入的分析。大体上,间质性和肺泡性水肿可以在脏层肺表面下区分开来。在组织学水平上,PGD 与弥漫性肺泡损伤(DAD)的模式相关。在细胞水平上,缺血再灌注损伤(IRI)是破坏内皮-上皮肺泡屏障和炎症级联反应的主要触发因素。整合所有与 PGD 相关方面的多层次方法可以更好地了解 LTx 后的急性肺衰竭,为未来的治疗提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/0bf659728ac1/cells-11-00745-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/b267ab35b5fa/cells-11-00745-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/0687b8af9a29/cells-11-00745-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/23a8e18af9c1/cells-11-00745-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/3e9bec5c9b56/cells-11-00745-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/461b06a0447d/cells-11-00745-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/7f9fd26c0454/cells-11-00745-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/0bf659728ac1/cells-11-00745-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/b267ab35b5fa/cells-11-00745-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/0687b8af9a29/cells-11-00745-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/23a8e18af9c1/cells-11-00745-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/3e9bec5c9b56/cells-11-00745-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/461b06a0447d/cells-11-00745-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/7f9fd26c0454/cells-11-00745-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/8870290/0bf659728ac1/cells-11-00745-g007.jpg

相似文献

1
A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome.临床肺移植后原发性移植物功能障碍的重点综述:一种多水平综合征
Cells. 2022 Feb 21;11(4):745. doi: 10.3390/cells11040745.
2
Primary graft dysfunction.原发性移植物功能障碍。
Semin Respir Crit Care Med. 2013 Jun;34(3):305-319. doi: 10.1055/s-0033-1348474. Epub 2013 Jul 2.
3
Local complement activation is associated with primary graft dysfunction after lung transplantation.局部补体激活与肺移植后原发性移植物功能障碍有关。
JCI Insight. 2020 Sep 3;5(17):138358. doi: 10.1172/jci.insight.138358.
4
Primary graft dysfunction: pathophysiology to guide new preventive therapies.原发性移植肝无功能:指导新型预防疗法的病理生理学
Expert Rev Respir Med. 2017 Feb;11(2):119-128. doi: 10.1080/17476348.2017.1280398. Epub 2017 Jan 20.
5
Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.在肺移植术后原发性移植肺功能障碍中,血管外肺水增加和急性肺损伤的血浆生物标志物先于氧合障碍出现。
Transplantation. 2017 Jan;101(1):112-121. doi: 10.1097/TP.0000000000001434.
6
Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation.长时间冷缺血导致缺血再灌注损伤中的细胞发生坏死性细胞死亡,并导致肺移植后原发性移植物功能障碍。
Am J Respir Cell Mol Biol. 2019 Aug;61(2):244-256. doi: 10.1165/rcmb.2018-0207OC.
7
Primary graft dysfunction after lung transplantation.肺移植后原发性移植物功能障碍。
Curr Opin Organ Transplant. 2023 Jun 1;28(3):180-186. doi: 10.1097/MOT.0000000000001065. Epub 2023 Apr 13.
8
Analysis of sex-based differences in clinical and molecular responses to ischemia reperfusion after lung transplantation.分析肺移植后缺血再灌注的临床和分子反应中的性别差异。
Respir Res. 2021 Dec 22;22(1):318. doi: 10.1186/s12931-021-01900-y.
9
Primary Graft Dysfunction.原发性移植物功能障碍。
Semin Respir Crit Care Med. 2021 Jun;42(3):368-379. doi: 10.1055/s-0041-1728794. Epub 2021 May 24.
10
Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.再灌注后立即出现的移植物功能障碍可预测活体供体肺叶移植的短期预后,但对尸体肺移植则不然。
Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):314-20. doi: 10.1093/icvts/ivv357. Epub 2015 Dec 23.

引用本文的文献

1
Optimizing patient outcomes in interstitial lung disease through pre- and post-transplant management strategies.通过移植前和移植后管理策略优化间质性肺疾病患者的治疗效果。
World J Transplant. 2025 Sep 18;15(3):101866. doi: 10.5500/wjt.v15.i3.101866.
2
Primary Graft Dysfunction in Lung Transplantation: An Overview of the Molecular Mechanisms.肺移植中的原发性移植功能障碍:分子机制概述
Int J Mol Sci. 2025 Jul 15;26(14):6776. doi: 10.3390/ijms26146776.
3
Assessment of postoperative outcomes of prescription benzodiazepine use in lung transplant recipients.

本文引用的文献

1
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.肺移植候选人选择的共识文件:国际心肺移植学会的更新。
J Heart Lung Transplant. 2021 Nov;40(11):1349-1379. doi: 10.1016/j.healun.2021.07.005. Epub 2021 Jul 24.
2
Lung Transplantation, Pulmonary Endothelial Inflammation, and Ex-Situ Lung Perfusion: A Review.肺移植、肺血管内皮炎症与体外肺灌注:综述
Cells. 2021 Jun 7;10(6):1417. doi: 10.3390/cells10061417.
3
Ischemia-Reperfusion Injury in Lung Transplantation.
肺移植受者使用处方苯二氮䓬类药物的术后结果评估。
J Thorac Dis. 2025 Jun 30;17(6):3737-3748. doi: 10.21037/jtd-2025-35. Epub 2025 Jun 25.
4
The comparative impact of central vs. peripheral VA-ECMO cannulation on postoperative graft dysfunction in lung transplantation: a retrospective analysis.中心与外周VA-ECMO插管对肺移植术后移植物功能障碍的比较影响:一项回顾性分析
Front Cardiovasc Med. 2025 Feb 25;12:1512742. doi: 10.3389/fcvm.2025.1512742. eCollection 2025.
5
Differentially expressed microRNAs in pre-transplant lung biopsies target immune checkpoint proteins and can predict primary graft dysfunction in lung transplantation.移植前肺活检中差异表达的微小RNA靶向免疫检查点蛋白,并可预测肺移植中的原发性移植物功能障碍。
Heliyon. 2025 Feb 8;11(4):e42515. doi: 10.1016/j.heliyon.2025.e42515. eCollection 2025 Feb 28.
6
The superiority of veno-arterial over veno-venous extracorporeal membrane oxygenation for operative support of lung transplantation.在肺移植手术支持中,静脉 - 动脉体外膜肺氧合相对于静脉 - 静脉体外膜肺氧合的优势。
BMC Pulm Med. 2025 Jan 20;25(1):30. doi: 10.1186/s12890-025-03483-6.
7
Enhancing lung transplantation with ECMO: a comprehensive review of mechanisms, outcomes, and future considerations.体外膜肺氧合辅助下增强肺移植:机制、结果及未来考量的全面综述
J Extra Corpor Technol. 2024 Dec;56(4):191-202. doi: 10.1051/ject/2024023. Epub 2024 Dec 20.
8
Improving lung allograft function in the early post-operative period through the inhibition of pyroptosis.通过抑制细胞焦亡改善肺移植术后早期的移植肺功能。
Med Rev (2021). 2024 May 16;4(5):384-394. doi: 10.1515/mr-2023-0066. eCollection 2024 Oct.
9
Mitigating the risk of inflammatory type primary graft dysfunction by applying an integrated approach to assess, modify and match risk factors in lung transplantation.通过采用综合方法评估、调整和匹配肺移植中的风险因素,降低炎症性原发性移植物功能障碍的风险。
Front Transplant. 2024 Aug 20;3:1422088. doi: 10.3389/frtra.2024.1422088. eCollection 2024.
10
Phenotyping of primary graft dysfunction after lung transplantation by in-depth biomarker analysis.通过深入的生物标志物分析对肺移植术后原发性移植功能障碍进行表型分析。
ERJ Open Res. 2024 Aug 5;10(4). doi: 10.1183/23120541.00439-2024. eCollection 2024 Jul.
肺移植中的缺血再灌注损伤。
Cells. 2021 May 28;10(6):1333. doi: 10.3390/cells10061333.
4
Innate immunity in lung transplantation.肺移植中的固有免疫。
J Heart Lung Transplant. 2021 Jul;40(7):562-568. doi: 10.1016/j.healun.2021.03.017. Epub 2021 Mar 26.
5
Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review.移植肺中的缺血再灌注损伤:文献综述
Transplant Direct. 2021 Jan 7;7(2):e652. doi: 10.1097/TXD.0000000000001104. eCollection 2021 Feb.
6
Novel Strategies for Endothelial Preservation in Lung Transplant Ischemia-Reperfusion Injury.肺移植缺血再灌注损伤中内皮细胞保护的新策略
Front Physiol. 2020 Dec 18;11:581420. doi: 10.3389/fphys.2020.581420. eCollection 2020.
7
Pulmonary Edema: A Pictorial Review of Imaging Manifestations and Current Understanding of Mechanisms of Disease.肺水肿:影像学表现及疾病机制的当前认识的图文综述
Eur J Radiol Open. 2020 Oct 30;7:100274. doi: 10.1016/j.ejro.2020.100274. eCollection 2020.
8
Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.抑制 ACSL4 可减轻肺缺血再灌注后的铁死亡损伤。
FASEB J. 2020 Dec;34(12):16262-16275. doi: 10.1096/fj.202001758R. Epub 2020 Oct 18.
9
Preconditioning with rHMGB1 ameliorates lung ischemia-reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway.rhHMGB1 预处理通过 Keap1/Nrf2/HO-1 信号通路抑制肺泡巨噬细胞焦亡减轻肺缺血再灌注损伤。
J Transl Med. 2020 Aug 5;18(1):301. doi: 10.1186/s12967-020-02467-w.
10
Local complement activation is associated with primary graft dysfunction after lung transplantation.局部补体激活与肺移植后原发性移植物功能障碍有关。
JCI Insight. 2020 Sep 3;5(17):138358. doi: 10.1172/jci.insight.138358.